Nick Leschly

2018 - bluebird bio

In 2018, Nick Leschly earned a total compensation of $24M as Chief Executive Officer at bluebird bio, a 173% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$465,888
Option Awards$16,719,582
Salary$610,000
Stock Awards$6,157,500
Other$9,250
Total$23,962,220

Leschly received $16.7M in option awards, accounting for 70% of the total pay in 2018.

Leschly also received $465.9K in non-equity incentive plan, $610K in salary, $6.2M in stock awards and $9.3K in other compensation.

Rankings

In 2018, Nick Leschly's compensation ranked 94th out of 14,244 executives tracked by ExecPay. In other words, Leschly earned more than 99.3% of executives.

ClassificationRankingPercentile
All
94
out of 14,244
99th
Division
Manufacturing
27
out of 5,762
100th
Major group
Chemicals And Allied Products
11
out of 2,125
100th
Industry group
Drugs
9
out of 1,814
100th
Industry
Biological Products, Except Diagnostic Substances
3
out of 339
99th
Source: SEC filing on April 23, 2019.

Leschly's colleagues

We found four more compensation records of executives who worked with Nick Leschly at bluebird bio in 2018.

2018

Jeffrey Walsh

bluebird bio

Chief Strategy Officer

2018

David Davidson

bluebird bio

Chief Medical Officer

2018

Philip Gregory

bluebird bio

Chief Scientific Officer

2018

Jason Cole

bluebird bio

Chief Operating and Legal Officer

News

In-depth

You may also like